BioSpace News Archive

FDA

AbbVie’s HUMIRA® (adalimumab) Receives U.S. FDA Approval For The Treatment Of Pediatric Patients With Moderately To Severely Active Crohn’s Disease

September 25, 2014
·
8 min read
Drug Development

Akebia Therapeutics, Inc. Announces Dosing Of First Patient In Phase 2 Study Of AKB-6548 In Patients With Anemia Related To Chronic Kidney Disease Undergoing Dialysis

September 25, 2014
·
1 min read
Drug Development

Blaze Bioscience Inc. Announces Initiation Of Phase 1b Brain Cancer Program For Tumor PaintTM BLZ-100

September 25, 2014
·
1 min read
Drug Development

Seattle Genetics, Inc. Highlights Updated Progression-Free Survival And Overall Survival Data From ADCETRIS® (Brentuximab Vedotin) Frontline PTCL Phase 1 Clinical Trial At The ESMO 2014 Congress

September 25, 2014
·
1 min read
NCKU Research Team Reveals Key Mechanism In Lung Cancer

September 25, 2014
·
1 min read
Biotech Beach

Ivera Medical Corporation Announces New Patent For Curos Strip Issued By USPTO

September 25, 2014
·
1 min read
Deals

Cambridge Healthtech Institute Announces The Acquisition Of OpenHelix

September 25, 2014
·
3 min read
Business

Covidien plc To Report Fourth-Quarter And Fiscal 2014 Results On November 5, 2014

September 25, 2014
·
1 min read
BioMidwest

LifeScience Alley® Names Winners For 2014 New Technology Showcase

September 25, 2014
·
1 min read
Medunik Canada Announces Health Canada Priority Review Of PHEBURANE© Indicated For The Treatment Of Urea Cycle Disorders (UCD)

September 25, 2014
·
3 min read